Prof. FATMA VİSAL OKUR

Publication Network

Articles 35

1. Evidence of Stem Cell Entrapment in AN69 Membranes During Continuous Renal Replacement Therapy.

Akbasli I. T., Saritas Nakib O., Kesici S., Okur F. V., Gucer K. S., Bayrakci B.

Artificial organs , 2025 (SCI-Expanded, Scopus)

2. Late Effects Following Hematopoietic Stem Cell Transplantation Among Childhood Transplant Survivors with Fanconi Anemia

Ozkocer C., Visal Okur F. V., Demirbilek H., Altintas B., Cetin N., Kuskonmaz B. B., et al.

TURKISH JOURNAL OF HEMATOLOGY , vol.42, no.1, pp.15-24, 2025 (SCI-Expanded, Scopus, TRDizin)

3. Navigating Hope and Complexity: Turkish Parents' Experiences with Savior Siblings

Eker I., Ozdemir H. N. c., Yilmaz F., Yesilipek A., Kupesiz A., Uygun V., et al.

TURKISH JOURNAL OF HEMATOLOGY , vol.42, no.1, pp.47-55, 2025 (SCI-Expanded, Scopus, TRDizin)

4. Calcineurin inhibitor-related hyperkalemia is caused by hyporeninemic hypoaldosteronism and fludrocortisone is an effective treatment: Report of a case series and review of the literature

ÜNSAL Y., BALTU D., GÜLHAN B., OKUR F. V., ÖZALTIN F., DÜZOVA A., et al.

PEDIATRIC TRANSPLANTATION , vol.28, no.4, 2024 (SCI-Expanded, Scopus) Sustainable Development

5. COVID-19 disease in children and adolescents following allogeneic hematopoietic stem cell transplantation: A report from the Turkish pediatric bone marrow transplantation study group

Bozkurt C., Hazar V., Malbora B., Kupesiz A., Aygunes U., Fisgin T., et al.

PEDIATRIC TRANSPLANTATION , vol.28, no.3, 2024 (SCI-Expanded, Scopus) Sustainable Development

6. Anti-human leukocyte antigen-DPB1 antibody-associated transfusion-related acute lung injury after hematopoietic stem cell infusion

BALKAN M. C., OKUR F. V., Apak F. B. B., Babayeva S., EKİCİ N. F., KUŞKONMAZ B. B., et al.

ASIAN JOURNAL OF TRANSFUSION SCIENCE , vol.18, no.1, pp.141-143, 2024 (ESCI, Scopus) Sustainable Development

7. Predictors of kidney complications and analysis of hypertension in children with allogeneic hematopoietic stem cell transplantation

Gurbanov A., GÜLHAN B., KUŞKONMAZ B. B., OKUR F. V., ÖZALTIN F., DÜZOVA A., et al.

PEDIATRIC NEPHROLOGY , vol.38, no.2, pp.461-469, 2023 (SCI-Expanded, Scopus)

8. First allogeneic hematopoietic stem cell transplantation in RASGRP1 deficiency: long-term follow-up.

Kuskonmaz B. B., Ayvaz D. N., Okur F. V., Aydın B., Tezcan I., Uckan Cetinkaya D.

Bone marrow transplantation , vol.57, pp.1210-1212, 2022 (SCI-Expanded, Scopus)

9. Thalassemia-free and graft-versus-host-free survival: outcomes of hematopoietic stem cell transplantation for thalassemia major, Turkish experience

Yesilipek M. A., Uygun V., Kupesiz A., Karasu G., Ozturk G., ERTEM M., et al.

BONE MARROW TRANSPLANTATION , vol.57, no.5, pp.760-767, 2022 (SCI-Expanded, Scopus)

10. Alterations in Hematopoietic and Mesenchymal Stromal Cell Components of the Osteopetrotic Bone Marrow Niche

Zeytin I. C., Alkan B., ÖZDEMİR SAKA C., ÇETİNKAYA F. D., OKUR F. V.

STEM CELLS TRANSLATIONAL MEDICINE , vol.11, no.3, pp.310-321, 2022 (SCI-Expanded, Scopus)

11. Association of Pre-Transplant Angiopoietin-2 Index with the Risk of Acute Graft-Versus-Host Disease after Hematopoietic Stem Cell Transplantation

ŞATIRER Ö., Zeytin I. C., Alkan B., KARAKAYA KARABULUT J., ÇETİNKAYA F. D., OKUR F. V.

TURKISH JOURNAL OF HEMATOLOGY , vol.39, no.1, pp.61-65, 2022 (SCI-Expanded, Scopus, TRDizin)

12. Different Kinetics and Risk Factors for Isolated Extramedullary Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Children with Acute Leukemia

Hazar V., Ozturk G., Yalcin K., Uygun V., AKSOYLAR S., Kupesiz A., et al.

TRANSPLANTATION AND CELLULAR THERAPY , vol.27, no.10, 2021 (SCI-Expanded, Scopus)

13. Fludrocortisone is the salvage treatment in cases with calcineurin inhibitor related hyperkalemia

Unsal Y., Baltu D., Gulhan B., Okur F. V., Duzova A., Ozon A., et al.

HORMONE RESEARCH IN PAEDIATRICS , vol.94, no.SUPPL 1, pp.193-194, 2021 (SCI-Expanded, Scopus)

14. Prognostic factors for survival in children who relapsed after allogeneic hematopoietic stem cell transplantation for acute leukemia

Hazar V., Tezcan Karasu G., ozturk G., Kupesiz A., AKSOYLAR S., ozbek N., et al.

PEDIATRIC TRANSPLANTATION , vol.25, no.5, 2021 (SCI-Expanded, Scopus)

15. EARLY URINARY SYSTEM COMPLICATIONS IN CHILDREN WITH HEMATOPOETIC STEM CELL TRANSPLANTATION

Gurbanov A., GÜLHAN B., KUŞKONMAZ B. B., OKUR F. V., ÇETİNKAYA F. D., Ozdemir G., et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION , vol.36, 2021 (SCI-Expanded, Scopus)

16. Pre-Conditioning Serum Uric Acid as a Risk Factor for Sinusoidal Obstruction Syndrome of the Liver in Children Undergoing Hematopoietic Stem Cell Transplantation Hematopoetik Kök Hücre Transplantasyonu Yapılan Çocuklarda Karaciğer Sinüzoidal Obstrüksiyon Sendromu için Bir Risk Faktörü Olarak Rejim Öncesi Serum Ürik Asit Düzeyi

OKUR F. V., Karapapak M., Warasnhe K., ARSLAN U. E., KUŞKONMAZ B. B., Çetinkaya D.

Turkish Journal of Hematology , vol.38, no.4, pp.286-293, 2021 (SCI-Expanded, Scopus, TRDizin)

17. First Allogeneic Hematopoietic Stem Cell Transplantation in RASGRP1 Deficieny

KUŞKONMAZ B. B., ÇAĞDAŞ AYVAZ D. N., OKUR F. V., Tezcan I., ÇETİNKAYA F. D.

BONE MARROW TRANSPLANTATION , vol.55, pp.653-654, 2020 (SCI-Expanded, Scopus)

18. Role of a second transplantation for children with acute leukemia following posttransplantation relapse: a study by the Turkish Bone Marrow Transplantation Study Group

Hazar V., Karasu G. T., Uygun V., Ozbek N., KARAKÜKCÜ M., Ozturk G., et al.

LEUKEMIA & LYMPHOMA , vol.61, no.6, pp.1465-1474, 2020 (SCI-Expanded, Scopus) Sustainable Development

19. Evaluation of Drug-Related Problems in a Pediatric Bone Marrow Transplantation Unit Identified by a Clinical Pharmacist in-training in a 7-Month Period

Ozdemir N., ÇELİKER A., KUŞKONMAZ B. B., OKUR F. V., Cetinkaya D. U.

CLINICAL AND EXPERIMENTAL HEALTH SCIENCES , vol.10, no.1, pp.21-26, 2020 (ESCI, TRDizin)

20. Coping and psychopathology in children with malignancy and bronchiectasis

BIKMAZER A., ÖRENGÜL A. C., Buyukdeniz A., OKUR F. V., GÖKDEMİR Y., PERDAHLI FİŞ N.

PEDIATRIC PULMONOLOGY , vol.55, no.1, pp.214-220, 2020 (SCI-Expanded, Scopus) Sustainable Development

21. Osteopetrotic induced pluripotent stem cells derived from patients with different disease-associated mutations by non-integrating reprogramming methods

OKUR F. V., Cevher I., ÖZDEMİR SAKA C., Kocaefe C., ÇETİNKAYA F. D.

STEM CELL RESEARCH & THERAPY , vol.10, 2019 (SCI-Expanded, Scopus)

22. Bone marrow transplantation with Favorable outcome in three patients with LPS-responsive beige like anchor (LRBA) deficiency

OKUR F. V., KUŞKONMAZ B. B., Cagdas D. N., Tezcan I., Uckan-Cetinkaya D.

CLINICAL IMMUNOLOGY , vol.203, pp.162-165, 2019 (SCI-Expanded, Scopus)

23. Clinical pharmacist's contribution on managing drug related problems in paediatric hematopoietic stem cell transplantation

Ozdemir N., ÇELİKER A., OKUR F. V., KUŞKONMAZ B. B., Cetinkaya D. U.

INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , vol.40, no.1, pp.274-275, 2018 (SCI-Expanded, Scopus)

24. Evaluation of drugs used in paediatric bone marrow transplantation unit in terms of drug interactions

Ozdemir N., Tecen K., KARA E., ÇELİKER A., OKUR F. V., KUŞKONMAZ B. B., et al.

INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , vol.40, no.1, pp.274, 2018 (SCI-Expanded, Scopus)

25. Hematopoietic stem cell transplantation in children with Griscelli syndrome: A single-center experience

Kuskonmaz B. B., ÇAĞDAŞ AYVAZ D. N., Gokce M., Ozgur T. T., OKUR F. V., Cetin M., et al.

PEDIATRIC TRANSPLANTATION , vol.21, no.7, 2017 (SCI-Expanded, Scopus)

26. Pluripotent Kök Hücreler: Embriyonik Kök Hücre ve Uyarılmış Pluripotent Kök Hücre

OKUR F. V.

TÜRKİYE KLİNİKLERİ PŞASTİK CERRAHİ , vol.3, no.4, pp.7-10, 2015 (Non Peer-Reviewed Journal)

27. Mezenkimal Kök Hücre ve Kemik İliği Mikroçevresi

OKUR F. V.

TÜRKİYE KLİNİKLERİ , vol.4, no.7, pp.19-23, 2014 (Peer-Reviewed Journal)

28. Acute in Vitro effects of ABS (Ankaferd Hemostat) on the Lymphoid Neoplastic Cells (B-CLL and RAJI Tumor Cell Lines)

AKALIN İ., Okur F. V., HAZNEDAROĞLU İ. C., SAYINALP N., AKSU S., BÜYÜKAŞIK Y., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.24, no.4, pp.253-259, 2014 (SCI-Expanded, Scopus, TRDizin)

29. Comparison of two CD40-ligand/interleukin-2 vaccines in patients with chronic lymphocytic leukemia.

Okur F. V., YVON E., BIAGI E., DOTTI G., CARRUM G., HESLOP H., et al.

Cytotherapy , vol.13, pp.1128-39, 2011 (SCI-Expanded, Scopus)

30. Clinical significance of serum vascular endothelial growth factor, endostatin, and leptin levels in children with lymphoma.

Okur F. V., KARADENIZ C., BUYUKPAMUKCU M., OGUZ A., YUCEL A., CINAZ P., et al.

Pediatric blood & cancer , vol.55, pp.1272-7, 2010 (SCI-Expanded, Scopus)

31. Stem Cell Transplantation in Childhood Non-Hodgkin's Lymphomas

Okur F. V., KRANCE R.

CURRENT HEMATOLOGIC MALIGNANCY REPORTS , vol.5, no.4, pp.192-199, 2010 (SCI-Expanded, Scopus)

32. Cellular immunotherapy of cancer.

Okur F. V., BRENNER M.

Methods in molecular biology (Clifton, N.J.) , vol.651, pp.319-45, 2010 (Scopus) Sustainable Development

33. Overview of gene therapy clinical progress including cancer treatment with gene modified T cells

Brenner M., OKUR F. V.

Hematology-American Society of Hematology Education Program , vol.2009, no.1, pp.675-681, 2009 (Scopus)

34. Selective depletion of a minor subpopulation of B-chronic lymphocytic leukemia cells is followed by a delayed but progressive loss of bulk tumor cells and disease regression.

FOSTER A., Okur F. V., BIAGI E., LU A., DOTTI G., YVON E., et al.

Molecular cancer , vol.8, pp.106, 2009 (SCI-Expanded, Scopus)

35. Evaluation of peripheral lymphadenopathy in children

OGUZ A., KARADENIZ C., TEMEL E. A., CITAK E. C., Okur F. V.

PEDIATRIC HEMATOLOGY AND ONCOLOGY , vol.23, no.7, pp.549-561, 2006 (SCI-Expanded, Scopus) Sustainable Development

Papers Presented at Peer-Reviewed Scientific Conferences 50

1. Are transfusion reactions associated with hematopoietic stem cell product infusion more frequent than previously thought?

Apak F. B. B., OKUR F. V., Cetin N., Balkan M., Warasnhe K., KUŞKONMAZ B. B., et al.

30th International Congress of The Transplantation-Society (TTS), İstanbul, Turkey, 22 - 25 September 2024, pp.492, (Summary Text)

2. EXPERIENCES OF PARENTS WHO CONCEIVED SAVIOR SIBLINGS FOR BEING HEMATOPOIETIC STEM CELL DONORS TO THEIR SICK CHILDREN AND SUCCESSFULLY COMPLETED THE PROCESS: A QUALITATIVE STUDY

Eker I., Ozdemir H. N. C., Yilmaz F., Yesilipek A., Kupesiz A., Uygun V., et al.

49th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, ELECTR NETWORK, 23 - 26 April 2023, pp.600-601, (Summary Text)

3. ANALYSIS OF LATE RENAL COMPLICATIONS AND RISK FACTORS IN CHILDREN WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION

Gurbanov A., GÜLHAN B., KUŞKONMAZ B. B., OKUR F. V., Cetinkaya D. U., Ozdemir G., et al.

57th ERA-EDTA Congress, ELECTR NETWORK, 6 - 09 June 2020, vol.35, pp.2140, (Summary Text)

4. EARLY URINARY SYSTEM COMPLICATIONS IN CHILDREN WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION

Gurbanov A., GÜLHAN B., KUŞKONMAZ B. B., OKUR F. V., Cetinkaya D. U., Ozdemir G., et al.

57th ERA-EDTA Congress, ELECTR NETWORK, 6 - 09 June 2020, vol.35, pp.2123, (Summary Text)

5. Pre-Transplant Angiopoietin Index Predicts the Development of Graft Versus Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Cimen O., Cevher I., Alkan B., KARAKAYA KARABULUT J., Cetinkaya D., OKUR F. V.

Transplantation and Cellular Therapy (TCT) Meetings of ASTCT and CIBMTR, Florida, United States Of America, 19 - 23 February 2020, vol.26, (Summary Text)

6. Modeling Hematopoietic Niche in Osteopetrosis Using Patient-Derived Induced Pluripotent Stem Cells

cevher i., Alkan B., ÖZDEMİR SAKA C., ÇETİNKAYA F. D., OKUR F. V.

ESGCT, Barcelona, Spain, 22 - 25 October 2019, (Summary Text)

7. Differentiation of Osteopetrotic IPSCs Towards Osteoclasts: Comparision of Osteopetrotic and Healthy Osteoclasts

CEVHER I., ALKAN B., ÇETİNKAYA F. D., OKUR F. V.

27th BCLF and 30th TBS, 27 - 31 October 2019, (Summary Text)

8. Niş benzeri kokültür sistemi ile AML lösemik kök hücrelerin tanımlanması ve karekterizasyonu

Alkan B., Cevher I., GÜLBAKAN B., AYTAC Ş. S., CETINKAYA D., OKUR F. V.

45. Ulusal Hematoloji Kongresi, Antalya, Turkey, 30 October - 02 November 2019, (Full Text)

9. Successful bone marrow transplantation from HLA 9/10 matched relative after myeloablative conditioning in a patient with PRKDC defect

KUŞKONMAZ B. B., ÇAĞDAŞ AYVAZ D. N., OKUR F. V., DEMİR H., TEZCAN F. İ., ÇETİNKAYA F. D.

ESID 2019-meeting, 18 - 21 September 2019, (Full Text)

10. Successful hematopoietic stem cell transplantation in a child with CD40 deficiency

KUŞKONMAZ B. B., ÇAĞDAŞ AYVAZ D. N., OKUR F. V., BARIŞ S., TEZCAN F. İ., UÇKAN ÇETİNMKAYA D.

Meeting of the European Society for Immunodeficiencies, Brussels, Belgium, September 18-21, 2019, 18 - 21 September 2019

11. Succesful bone marrow transplantation from HLA 9/10 matched relative after myeloablative conditioning in a patient with PRKDC defect

Kuskonmaz B. B., Cagdas D. N., OKUR F. V., Tezcan I., DEMİR H., ÇETİNKAYA F. D.

ESID, Brüksel, Belgium, 18 - 21 September 2019, (Summary Text)

12. Studies on Induced Pluripotent Stem Cell (iPSC) Banking in Turkey

AYGAR S., CEVHER I., ALKAN B., KILIC E., BAYRAKTAR K., OKUR F. V., et al.

3rd International Congress on Advances in Bioscience and Biotechnology (ICABB), 10 - 14 July 2019, (Summary Text)

13. Hematopoetik Kök Hücre Nakli Yapılan Çocuk Hastalarda Erken Dönem Üriner Sistem Komplikasyonları

Gurbanov A., GÜLHAN B., KUŞKONMAZ B. B., OKUR F. V., Uçkan Çetinkaya D., Özdemir G., et al.

10. Çocuk Nefrolojisi Kongresi, Turkey, 1 - 04 May 2019, (Summary Text)

14. Hematopoetik Kök Hücre Nakli Yapılan Çocuk Hastalarda Geç Dönem Renal Komplikasyonların Ve RiskFaktörlerinin Analizi

Gurbanov A., GÜLHAN B., KUŞKONMAZ B. B., OKUR F. V., Uçkan Çetinkaya D., Özdemir G., et al.

10. Çocuk Nefrolojisi Kongresi, Turkey, 1 - 04 May 2019, (Summary Text)

15. Hematopoietic differentiation potential of induced pluripotent stem cells derived from osteopetrosis patients’xx peripheral blood mononuclear cells

Cevher I., Alkan B., Ozdemir C., CETINKAYA D., OKUR F. V.

ISSCR International Symposia, Amsterdam, Netherlands, 20 - 22 February 2019, (Summary Text)

16. Relapse after allogeneic hematopoietic stem cell transplantation for acute leukemia in children: a survey by the Turkish Pediatric Bone Marrow Transplantation Study Group of 255 cases

HAZAR V., TEZCAN KARASU G., ÖZTÜRK H. G., KÜPESİZ O. A., KANSOY S., ÖZBEK N., et al.

The 44th Annual Meeteng of the European Society for Blood and Marrow Transplantation, 18 - 21 March 2018, (Full Text)

17. RELAPS AKUT LÖSEMİSİ OLAN PEDİATRİK OLGULARDAİKİNCİ HEMATOPOİETİK KÖK HÜCRE NAKİL SONUÇLARI

HAZAR V., KARASU G., UYGUN V., ÖZBEK N. Y., KARAKÜKCÜ M., ÖZTÜRK H. G., et al.

44.ULUSAL HEMATOLOJİ KONGRESİ, Turkey, 31 October - 03 November 2018, pp.195, (Full Text)

18. Malignite ve BronşektaziliÇocuklarda Başa Çıkma ve Psikopatoloji

BIKMAZER A., Orengul C., Büyükaslan A., GÖKDEMİR Y., OKUR F. V., KARADAĞ B. T., et al.

Çocuk Göğüs Hastalıkları 3. Kongresi, İstanbul, Turkey, 26 - 28 September 2018, pp.102, (Summary Text)

19. Extracorporeal Photopheresis for Graft versus Host Disease in Pediatric Patients: A Pilot Single Institution Report

OKUR F. V., KUŞKONMAZ B. B., Cetin N., Demirsu A., TAŞDEMİR O. A., Cetinkaya D. U.

44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Lisbon, Portugal, 18 - 21 March 2018, vol.53, pp.414-415, (Summary Text)

20. Relapse after allogeneic hematopoietic stem cell transplantation for acute leukemia in children: a survey by the Turkish Pediatric Bone Marrow Study Group of 255 cases

Hazar V., Karasu G. T., Ozturk G., Kupesiz A., KANSOY S., Ozbek N., et al.

44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Lisbon, Portugal, 18 - 21 March 2018, vol.53, pp.182-183, (Summary Text)

21. Successful Hematopoetic Stem Cell Transplantation with Non-Myeloablative conditioning in a patient with Primary Pulmonary Alveolar Proteinosis

Ozcelik U., Aytac Ş. S., KUŞKONMAZ B. B., Yalcin E., Ersoz D. D., Okur V., et al.

44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Lisbon, Portugal, 18 - 21 March 2018, vol.53, pp.723, (Summary Text)

22. Leucoderma and leucotrichia in association with chronic cutaneous graft-versus-host disease in a child with Wiskott-Aldrich syndrome

KUŞKONMAZ B. B., OKUR F. V., Cetin N., Teker S., Cetinkaya D. U.

44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Lisbon, Portugal, 18 - 21 March 2018, vol.53, pp.707-708, (Summary Text)

23. GENERATION OF INDUCED PLURIPOTENT STEM CELLS FROMMESENCHYMAL STEM CELLS OF OSTEOPETROSIS PATIENTSBY TWO DIFFERENT INTEGRATION-FREE METHODS UNDERFEEDER-FREE CONDITIONS

OKUR F. V., CEVHER İ., KILIÇ E., ÖZDEMİR SAKA C., KOCAEFE Y. Ç., ÇETİNKAYA F. D.

ISCT, 2 - 05 May 2018, (Full Text)

24. Hematopoietic stem cell transplantation in childrenwith Wiskott-Aldrich syndrome with myeloablativeconditioning

KUŞKONMAZ B. B., OKUR F. V., ÇAĞDAŞ AYVAZ D. N., AYTAÇ EYÜPOĞLU Ş. S., TEZCAN F. İ., ÇETİNKAYA F. D.

The 44th Annual Meeting of the European Society for Blood and Marrow Transplantation. 18–21 March 2018. Lisbon, Portugal, 18 - 21 March 2018, (Summary Text)

25. Relapse after allogeneic hematopoietic stem cell transplantation for acute leukemıa in children: a survey by theTurkish pediatricbone marrow study group of 225 cases.

HAZAR V., TEZCAN G., ÖZTÜRK G., KÜPESİZ O. A., KANSOY S., ÖZBEK N. Y., et al.

44th EBMT Annual Meeting, Lisbon, PORTEKİZ., LİZBON, Portugal, 18 - 21 March 2018, vol.1, pp.135, (Full Text)

26. Hematopoietic stem cell transplantation in children with Wiskott-Aldrich syndrome with myeloablative conditioning

KUŞKONMAZ B. B., OKUR F. V., ÇAĞDAŞ AYVAZ D. N., AYTAÇ EYÜPOĞLU Ş. S., TEZCAN F. İ., ÇETİNKAYA F. D.

EBMT 2018, Lisbon, Portugal, 18 - 21 March 2018, (Full Text)

27. Akut lösemili çocuklarda allojenik hematopoetik kök hücre nakli sonrasındarelpsda tedavi yaklaşımları

HAZAR V., KARASU G., öztürk G., KÜPESİZ O. A., KANSOY S., özbek n., et al.

10. ulusal kemik iliği transplantasyonu ve hücresel tedaviler kongresi, 1 - 03 March 2018, (Full Text)

28. Çocuklarda Hematopoetik Kök Hücre Nakli Sonrası Prognozu Belirlemede Modifiye Ebmt Risk Skorlamasının Kullanımı

GEZGEN KESEN G., POTAS KAYA N., OKUR F. V., OK BOZKAYA İ., AKSU T., KUŞKONMAZ B. B., et al.

10. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, 1 - 03 March 2018, (Summary Text)

29. Çocuklarda Hematopoietik Kök Hücre Nakli Sonrası Prognozun Belirlenmesinde Modifiye EBMT Skorlamasının Kullanımı

OKUR F. V., Kuskonmaz B. B., ÇETİNKAYA F. D., Aksu T., Ozbek N.

10. THD Ulusal Kemik İliği Transplantasyonu ve Hücresel, Turkey, 1 - 03 March 2018, (Full Text)

30. Tyrosine Kinase Inhibitor Responses in Pediatric CML Patients: Hacettepe Experience

YAMAN BAJİN H. İ., AYTAÇ EYÜPOĞLU Ş. S., KUŞKONMAZ B. B., ÜNAL CANGÜL Ş., OKUR F. V., ÇETİNKAYA F. D., et al.

49th Congress of the International Society of Paediatric Oncology (SIOP) Washington, DC, USA October 12–15, 2017, Washington, Kiribati, 12 - 15 October 2017, vol.64, pp.202, (Summary Text)

31. Childhood leukemia in an ETV6-related Thrombocytopenia family.

YAMAN BAJİN H. İ., AYTAÇ EYÜPOĞLU Ş. S., KUŞKONMAZ B. B., ÜNAL CANGÜL Ş., OKUR F. V., ÇETİNKAYA F. D., et al.

49th Congress of the International Society of Pediatric Oncology (SIOP), Washington, Kiribati, 12 - 15 October 2017, vol.64, pp.192, (Summary Text)

32. Clinical Pharmacists’ Contribution On Managing Drug Related Problems In Paediatric Hematopoietic Stem Cell Transplantation

ÖZDEMİR N., ÇELİKER A., OKUR F. V., KUŞKONMAZ B. B., ÇETİNKAYA F. D.

46th ESCP Symposium On Clinical Pharmacy, 9 - 11 October 2017, (Summary Text)

33. Evaluation Of Drugs Used İn Paediatric Bone Marrow Transplantation Unit In Terms Of Drıg İnteractions

ÖZDEMİR N., TECEN YÜCEL K., KARA E., ÇELİKER A., OKUR F. V., KUŞKONMAZ B. B., et al.

46th ESCP Symposium on Clinical Pharmacy, Heidelberg, Germany, 9 - 11 October 2017, (Summary Text)

34. Remission after allogeneic hematopoietic stem celltransplantation in a patient with LPS-responsive beige-likeanchor (LRBA) gene mutation

OKUR F. V., KUŞKONMAZ B. B., ÇAĞDAŞ AYVAZ D. N., aksu T., ÇETİN M., TEZCAN F. İ., et al.

43rd Annual Meeting of the European Society forBlood and Marrow Transplantation, 26 - 29 March 2017, (Summary Text)

35. Successful bone marrow transplantation aftermyeloablative conditioning in a child with IPEX syndrome

KUŞKONMAZ B. B., ÇAĞDAŞ AYVAZ D. N., ABUR M., OKUR F. V., KARAGÜZEL G., ORHAN F., et al.

43rd Annual Meeting of the European Society forBlood and Marrow Transplantation, 26 March - 22 December 2017, (Summary Text)

36. Remission after allogeneic hematopoietic stem cell transplantation in a patient with LPS‐responsivebeige‐like anchor (LRBA) gene mutation

OKUR F. V., KUŞKONMAZ B. B., ÇAĞDAŞ AYVAZ D. N., aksu T., ÇETİN M., TEZCAN F. İ., et al.

EBMT 2017, 26 - 29 March 2017, (Full Text)

37. Successful bone marrow transplantation after myeloablative conditioning in a child with IPEX syndrome

KUŞKONMAZ B. B., ÇAĞDAŞ AYVAZ D. N., haktanır abul m., OKUR F. V., KARAGÜZEL G., ORHAN F., et al.

EBMT 2017, 26 - 29 March 2017, (Full Text)

38. Pediatrik Kemik İliği Nakli Ünitesinde Kullanılan İlaçların İlaç Etkileşimleri Açısından Değerlendirilmesi

ÖZDEMİR N., TECEN YÜCEL K., KARA E., ÇELİKER A., OKUR F. V., KUŞKONMAZ B. B., et al.

3. Ulusal Klinik Eczacılık Farmasötik Bakım Kongresi, Antalya, Turkey, 9 - 12 February 2017, (Summary Text)

39. Pediatrik Kemik İliği Nakil Ünitesinde Kullanılan İlaçların İlaç Etkileşimleri Açısından Değerlendirilmesi

ÖZDEMİR N., TECEN YÜCEL K., KARA E., ÇELİKER A., OKUR F. V., KUŞKONMAZ B. B., et al.

3. Ulusal Klinik Eczacılık Farmasötik Bakım Kongresi, Turkey, 9 - 12 February 2017, (Summary Text)

40. Generation of induced pluripotent stem cells from human mesenchymal stem cells by sendai virus vectors

PEHLİVANOĞLU S., INCI C., EMINE K., ÇELEBİ SALTIK B., ÇETİNKAYA F. D., OKUR F. V.

Sanko University Innovation in Medicine Summit-2, 5 - 07 May 2016, (Summary Text)

41. Reprogramming of human mesenchymal stem cells from healthy donors and patients with osteopetrosis with non integrating RNA virus on feeder free conditions

OKUR F. V., CEVHER İ., kilic e., pehlivanoglu s., uckancetinkaya d., celebi saltık B.

13th National Histology and Embryology Congress with International Participation. April 30- May 3, 2016, İzmir, Turkey, 30 April - 03 May 2016, (Summary Text) Sustainable Development

42. Pediatrik hematopoietik kök hücre nakli sonrasında görülen dirençli sitopenilerin rituksimab ile tedavi sonuçları

AKSU T., KUŞKONMAZ B. B., OKUR F. V., ÜNAL CANGÜL Ş., ÇETİNKAYA F. D.

9. Ulusal Kemik İliği Transplantasyonu ve Kök Hücre Tedavileri Kongresi, 03 March 2016, (Summary Text)

43. Favorable Response to Rituximab in Refractory Cytopenias Occurring After Pediatric Hematopoietic Stem Cell Transplantation

AKSU T., KUŞKONMAZ B. B., OKUR F. V., ÜNAL S., Cetinkaya D. U.

42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, Valencia, Spain, 3 - 06 April 2016, vol.51, (Summary Text)

49. UNDERSTANDING AND MANAGEMENT OF DISEASE SPECIFIC COMPLICATIONS BY HSCT NURSES IN MALIGNANT INFANTILE OSTEOPETROSIS DURING THE COURSE OF HSCT

Cetin N., KIRAÇ F., Kucukyavuz E., Tavil B., OKUR F. V., KUŞKONMAZ B. B., et al.

41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Turkey, 22 - 25 March 2015, vol.50, pp.5526-5527, (Summary Text)

50. Effects of chimeric antigen receptor ( CAR) expression on regulatory T cells

Akalin I., Perna S., Biagio D. A., OKUR F. V., Rooney C., Heslop H., et al.

American Society of Gene Therapy, 27 - 30 May 2009, vol.17, pp.25, (Full Text)

Metrics

Publication

Publication (WoS)

Publication (Scopus)

Citation (WoS)

110

H-Index (WoS)

Citation (Scopus)

136

H-Index (Scopus)

Project

Open Access

UN Sustainable Development Goals

Publications & Works

Publication

Publication (WoS)

Publication (Scopus)

Citation (WoS)

H-Index (WoS)

Citation (Scopus)

H-Index (Scopus)

Project

Open Access